Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of € (6.5) ...
HUNTSVILLE, ALABAMA / ACCESS Newswire / January 19, 2026 / Curiteva, Inc., a leading privately held, technology-driven manufacturing company, announces the recent 510(k) clearance from the FDA for a ...
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, SE / ACCESS Newswire / January 19, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a ...
The US regulatory agency has set the target date for the final approval decision, known as the PDUFA date, as of September 3rd, 2026.PARIS--(BUSINESS WIRE)--Regulatory News:Advicenne (Euronext Growth ...
VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today ...
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...
Pro Forma Revenue Expected to exceed $20M (~4x 2024 Revenue)Wattbike Air-Pro Sells 700+ Units / ~$2.5M in UK Commercial ...
AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving ...
The Coca-Cola Company today announced a series of leadership changes designed to bring the business closer to consumers and ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile